Resolutions passed at the annual general meeting of Chr. Hansen Holding A/S


COMPANY ANNOUNCEMENT NO.24/2010, November 30, 2010

At the annual general meeting of Chr. Hansen Holding A/S held on 30 November
2010, the following business was transacted: 

• Adoption of the annual report 2009/10 and discharge of the Board of Directors
and the Management Board. 
• It was resolved to pay a dividend of DKK 0.64 per share of DKK 10.
• It was resolved to remunerate board members with a basis fee of DKK 300,000.
However, the chairman will receive 3 times the basis fee and the deputy
chairman one 1½ times the basis fee. Furthermore, the committee positions will
be remunerated with one third of the basis fee and the chairman of the audit
board will be remunerated with one half of the basis fee. 
• Ole Andersen was re-elected Chairman of the Board of Directors.
• Frédéric Stévénin, Gaëlle d'Engremont, Alice Dautry and Henrik Poulsen were
re-elected to the Board of Directors. Mark Wilson was elected as new member of
the Board of Direc-tors. 
• PricewaterhouseCoopers, Statsautoriseret Revisionsaktieselskab was
re-appointed as auditor of the company. 
• The Board of Directors was authorised to let the company purchase own shares,
in the period ending on 29 November 2015, to an extent that the total
shareholding of own shares in the company will not exceed 10 % of the share
capital. The purchase price for the shares must not deviate more than 10 % from
the price quoted at the time of the acquisi-tion for the company's shares on
Nasdaq OMX Copenhagen A/S. 
• The chairman of the meeting, attorney-at-law Søren Meisling, was authorised
to apply for registration of the resolutions passed and to make any such
amendments thereto as may be required or requested by the Danish Commerce and
Companies Agency as a condition for registration or approval. 


For further information, please contact:

Ole Andersen, Chairman
Tel: +45 4574 7109

Lars Frederiksen, CEO
Tel: +45 4574 7474

Ulrik Soendergaard, Corporate Communications
Tel: +45 4574 7109 



About Chr. Hansen
Chr. Hansen is a global bioscience company that develops natural ingredient
solutions for the food, nutritional, pharmaceutical and agricultural
industries. The products are centered around cultures, enzymes, probiotics and
natural colors, and all solutions are based on strong research and development
competencies coupled with significant technology investments. Revenue in the
2009/10 financial year was EUR 576 million. The company holds a leading market
position in all its divisions: Cultures & Enzymes, Health & Nutrition and
Colors & Blends. It has more than 2,300 dedicated employees in over 30
countries. Chr. Hansen was founded in 1874 and is today listed on NASDAQ OMX
Copenhagen. For further information, please visit www.chr-hansen.com.

Attachments

chrhansen_companyannouncement_annualgeneralmeeting_uk_301110.pdf
GlobeNewswire